Results 161 to 170 of about 74,008 (304)

A real‐time text‐based assessment tool for monitoring symptoms and quality of life for multiple myeloma patients: A feasibility study

open access: yesBritish Journal of Haematology, EarlyView.
Summary Patient‐reported outcome (PRO) and quality of life (QoL) assessments for multiple myeloma (MM) patients are traditionally collected at infrequent intervals using burdensome instruments, resulting in limited clinical visibility between visits. This creates a critical gap in care, as evolving symptoms and treatment‐related toxicities frequently ...
Victor Tellez   +12 more
wiley   +1 more source

Mapping the de-implementation of traditional diagnostic tests in pediatric acute lymphoblastic leukemia. [PDF]

open access: yesFront Oncol
Salek M   +8 more
europepmc   +1 more source

CD20 antigen loss post‐venetoclax/anti‐CD20 therapy in chronic lymphocytic leukaemia: Frequency, characteristics and potential therapeutic implications

open access: yesBritish Journal of Haematology, EarlyView.
Summary Venetoclax plus anti‐CD20 monoclonal antibody (mAb) regimens have revolutionised treatment for chronic lymphocytic leukaemia (CLL); however, CD20 antigen loss is a potential consequence. Given emerging roles for re‐treatment with venetoclax plus anti‐CD20 mAb and CD20‐targeting bispecific antibodies in CLL, we retrospectively assessed the ...
Tamasine Stewart   +15 more
wiley   +1 more source

Clinical course, risk factors, and therapeutic response in multiple myeloma with central nervous system involvement. [PDF]

open access: yesBlood Adv
Xiao A   +19 more
europepmc   +1 more source

Molecular heterogeneity and prognostic biomarkers in primary meningeal melanocytic tumors

open access: yesBrain Pathology, EarlyView.
Integrated molecular profiling reveals biological heterogeneity among primary meningeal melanocytic tumors, identifying intermediate‐grade PMMT subgroups with distinct recurrence risk. Molecular alterations including SF3B1 mutations and chromosome 8q gains support prognostic stratification, while PRKAR1A alterations and chromosome 17/21q losses aid ...
Rosina Paterra   +6 more
wiley   +1 more source

Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybridization in chronic lymphocytic leukemia in Taiwan, an area with low incidence-clinical implication and comparison between the West and the East

open access: yes, 2014
Chronic lymphocytic leukemia (CLL) is much less prevalent in Taiwan than in the West, but we have recently addressed the distinctly increasing incidence of CLL in Taiwan. We sought to find out whether there is any difference in cytogenetic abnormalities (
Wu, Shang-Ju;Lin, Chien-Ting;Huang, Sheng-Yi;Lee, Fen-Yu;Liu, Ming-Chi;Hou, Hsin-An;Chen, Chien-Yuan;Ko, Bor-Sheng;Chou, Wen-Chien;Yao, Ming;Tang, Jih-Luh;Tsay, Woei;Tien, Hwei-Fang   +1 more
core  

Association between chronic kidney disease and the risk of myelodysplastic syndromes: A large claims database study in Japan

open access: yes
British Journal of Haematology, EarlyView.
Yuta Baba   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy